A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

The SCORPIO-PEP trial found the drug ensitrelvir, already approved in Japan to treat people with mild to moderate COVID-19, may protect against the illness. In the study, uninfected people who began ...

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

The treatment of choice for a while. In 2020, then-President Donald Trump said he had been taking hydroxychloroquine to prevent a COVID-19 infection, despite warnings by the U.S. Food and Drug ...

This week, a scientific journal’s publisher retracted an influential study that claimed to show the drug hydroxychloroquine could treat covid-19, following years of criticism over the study’s ...

The U.S. Food and Drug Administration is considering the drug for fast-track approval as a way to prevent COVID-19, based on this latest study presented at the Conference of Retroviruses and ...

Donald Trump has touted the anti-malarial drug as a COVID-19 "game changer." Not many had heard of hydroxychloroquine at the start of the year. Back in January, some doctors in China began ...

Study concludes COVID-19 'is not a laboratory construct' Some have suggested the virus is actually an engineered biological attack. By Kate Holland. March 27, 2020, 5:00 AM. 2:28.

COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...